PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.7500
-0.0180 (-2.34%)
At close: Mar 28, 2025, 4:00 PM
0.7203
-0.0297 (-3.96%)
After-hours: Mar 28, 2025, 5:27 PM EDT
PAVmed Stock Forecast
PAVM's stock price has decreased by -72.53% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for PAVmed stock has a target of 19, which predicts an increase of 2,433.33% from the current stock price of 0.75.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 9, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for PAVmed is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $21 → $19 | Strong Buy | Maintains | $21 → $19 | +2,433.33% | Dec 9, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +2,700.00% | Sep 10, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7.5 → $7 | Strong Buy | Maintains | $7.5 → $7 | +833.33% | Sep 6, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $8.61 | Hold | Reiterates | $8.61 | +1,048.00% | Aug 18, 2023 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.25 → $7.25 | Strong Buy | Maintains | $8.25 → $7.25 | +866.67% | Apr 10, 2023 |
Financial Forecast
Revenue This Year
13.08M
from 3.00M
Increased by 336.66%
Revenue Next Year
52.33M
from 13.08M
Increased by 300.11%
EPS This Year
-1.48
from 0.61
EPS Next Year
-0.52
from -1.48
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 39.7M | 105.6M | 192.8M | ||
| Avg | 13.1M | 52.3M | 187.3M | ||
| Low | 196,000 | 2.0M | 179.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1,225.2% | 707.7% | 268.4% | ||
| Avg | 336.7% | 300.1% | 257.9% | ||
| Low | -93.5% | -85.0% | 243.9% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -1.22 | -0.41 |
| Avg | -1.48 | -0.52 |
| Low | -1.72 | -0.61 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.